Clinical Trials
5 trialsNCT06314698 2024-03-18
Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
RenJi Hospital
Phase 3 Not yet recruiting
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT02439112 2020-12-17
EMMY
Zealand University Hospital
Phase NA Completed
NCT01582295 2017-05-25
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Massachusetts General Hospital
Phase 1 Completed
NCT00741377 2013-02-18
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Novartis
Phase 1 Completed